Page last updated: 2024-11-07

nsc 30705

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

NSC 30705: RN given refers to parent cpd; structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID95714
CHEMBL ID120756
MeSH IDM0127903

Synonyms (24)

Synonym
p-benzoquinone (8ci),5-bis(1-aziridinyl)-3,6-dichloro-
nsc30705
2,4-dione (9ci), 2,5-bis(1-aziridinyl)-3,6-dichloro-
7251-14-1
nsc-30705
CHEMBL120756
2,5-bis(aziridin-1-yl)-3,6-dichlorocyclohexa-2,5-diene-1,4-dione
AKOS024341721
p-benzoquinone (8ci), 2,5-bis(1-aziridinyl)-3,6-dichloro-
ai3-50729
unii-b4v33s09hy
nsc 30705
2,5-cyclohexadiene-1,4-dione, 2,5-bis(1-aziridinyl)-3,6-dichloro-
b4v33s09hy ,
tw 14
DTXSID40222825
tw-14
p-benzoquinone, 2,5-bis(1-aziridinyl)-3,6-dichloro-
2,5-bis-aziridin-1-yl-3,6-dichloro-(1,4)benzoquinone
rq-2
2,5-dichloro-3,6-diaziridinyl-1,4-benzoquinone
2,5-bis(1-aziridinyl)-3,6-dichloro-p-benzoquinone
2,5-diethylenimino-3,6-dichloro-1,4-benzoquinone
2,5-bis(1-aziridinyl)-3,6-dichloro-2,5-cyclohexadiene-1,4-dione
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (8)

Assay IDTitleYearJournalArticle
AID228716log 1/anion production.1996Journal of medicinal chemistry, Feb-02, Volume: 39, Issue:3
In vivo activity and hydrophobicity of cytostatic aziridinyl quinones.
AID19922E1/2 for the half-wave potential at pH=7.0 in V571996Journal of medicinal chemistry, Feb-02, Volume: 39, Issue:3
In vivo activity and hydrophobicity of cytostatic aziridinyl quinones.
AID72099log 1/MIC for fungi in mmol/L1996Journal of medicinal chemistry, Feb-02, Volume: 39, Issue:3
In vivo activity and hydrophobicity of cytostatic aziridinyl quinones.
AID1144895Antitumor activity against mouse L1210 cells allografted in ip dosed mouse administered qd on day 1, 5 and 9 relative to control1976Journal of medicinal chemistry, Feb, Volume: 19, Issue:2
Potential central nervous system antitumor agents. Aziridinylbenzoquinones. 1.
AID94809In vitro cytotoxicity tested against human chronic leukemia K562 cells1997Journal of medicinal chemistry, Jan-31, Volume: 40, Issue:3
Cross-linking and sequence specific alkylation of DNA by aziridinyl quinones. 2. Structure requirements for sequence selectivity.
AID18769Observed rate of hydrolysis (logKobs) (pH=4.0)1996Journal of medicinal chemistry, Feb-02, Volume: 39, Issue:3
In vivo activity and hydrophobicity of cytostatic aziridinyl quinones.
AID1144818Antitumor activity against mouse L1210 cells allografted in ip dosed mouse1976Journal of medicinal chemistry, Feb, Volume: 19, Issue:2
Potential central nervous system antitumor agents. Aziridinylbenzoquinones. 1.
AID97909log 1/ID75 for the in vitro clonogenic L1210 assay with ID75 in umol/L1996Journal of medicinal chemistry, Feb-02, Volume: 39, Issue:3
In vivo activity and hydrophobicity of cytostatic aziridinyl quinones.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (5)

TimeframeStudies, This Drug (%)All Drugs %
pre-19903 (60.00)18.7374
1990's2 (40.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other5 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]